About this article Cite this article Knottnerus, S.J.G., Bleeker, J.C., Wst, R.C.I
While the mechanism is not yet proven, there is support for the idea that GLP-1 attenuates the ras homolog gene family, member A (RhoA)/Rho-associated protein kinase (ROCK) signaling pathway, whose activation is known to reduce levels of occludin, claudin-5, and zonula occludens-1 (ZO-1), as well as promote disruption of endothelial tight junctions
Phytomedicine 60, 152954
Reduced NO bioavailability and associated impairments in NOsGCcGMP signalling have been associated with CKD onset and progression in diabetes
(Study: Frias et al., 2021) Dual Agonism: Tirzepatide's distinctive dual mechanism of action combines GLP-1 receptor activation with glucagon receptor activation, potentially resulting in even more pronounced weight loss compared to traditional GLP-1 RAs